Cyanide

Cyanide

SCHEMBL25407293

C#N.C#N.NN=Cc1ccc2cc[nH]c(=O)c2c1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 2/20 0.41
▸ CHEK1 O14757 1/20 0.41
▸ ATIC P31939 2/20 0.39
▸ CYP2A6 P11509 2/20 0.35
▸ JAK2 O60674 1/20 0.34
▸ RPS6KA3 P51812 1/20 0.34
▸ MELK Q14680 1/20 0.34
▸ STK24 Q9Y6E0 1/20 0.34
▸ GRIN2D O15399 1/20 0.34
▸ GRIN3B O60391 1/20 0.34
▸ GRIN1 Q05586 1/20 0.34
▸ GRIN2A Q12879 1/20 0.34
▸ GRIN2B Q13224 1/20 0.34
▸ GRIN2C Q14957 1/20 0.34
▸ GRIN3A Q8TCU5 1/20 0.34
▸ ROCK2 O75116 2/20 0.33
▸ ROCK1 Q13464 4/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ TYMS P04818 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29955132 0.76 CYP2A6 (0.59) PARP1CHEK1ATICCYP2A6ROCK2
Cyanide SCHEMBL22130248 0.75 GRIN2D (0.57) CYP2A6GRIN2DGRIN3BGRIN1GRIN2A
Cyanide SCHEMBL25404043 0.71 CYP2A6 (0.38) CYP2A6MAOB
SCHEMBL7422567 0.71 PARP1 (0.52) PARP1CHEK1ATICJAK2RPS6KA3
Cyanide SCHEMBL25406727 0.69 PARP1 (0.51) PARP1JAK2RPS6KA3MELKSTK24
Cyanide SCHEMBL25405038 0.69 CA12 (0.46) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Cyanide SCHEMBL25407117 0.69 — —
SCHEMBL30349914 0.69 PARP1 (0.53) PARP1CHEK1ATICJAK2RPS6KA3
SCHEMBL3004117 0.69 PARP1 (0.53) PARP1CHEK1ATICJAK2RPS6KA3
Cyanide SCHEMBL22130249 0.68 NPC1 (0.53) CYP2A6GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US claimed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP claimed
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed
EP-4169905-A1 NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF Korea Institute of Science and Technology (KR) 2023-04-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT PARP1 1043/4885CHEK1 994/4885ATIC 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback